New blood test could spot cervical cancer early in High-Risk women
NCT ID NCT07606677
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to develop a blood test that can accurately detect serious cervical lesions in women infected with HPV16 or HPV18, the high-risk types linked to cervical cancer. Researchers will collect blood samples and medical data from about 1,465 women across three hospitals in China. The goal is to create an immune-based model that could help identify who needs further testing, potentially reducing unnecessary biopsies and catching cancer early.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CERVICAL CANCER (EARLY DETECTION) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a Light-Activated cream replace surgery for cervical precancer?
- New cream after heat treatment may help women with HIV beat HPV
- Can a simple HPV test replace colposcopy for cervical cancer Follow-Up?
- New Self-Test could revolutionize cervical cancer screening
- Turmeric trial for cervical precancer pulled before it began
- Can the HPV vaccine stop cervical abnormalities from returning after surgery?